JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB189249

Anti-PAX8 抗体 [EPR13511] - C-terminal

Anti-PAX8 antibody [EPR13511] - C-terminal

  • 20ul selling size
  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • 詳細を見る

4

(1 Review)

|

(21 Publications)

Rabbit Recombinant Monoclonal PAX8 antibody. C-terminal. Suitable for IHC-P and reacts with Human samples. Cited in 21 publications.

別名を表示する

Paired box protein Pax-8, PAX8

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [EPR13511] - C-terminal (AB189249)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [EPR13511] - C-terminal (AB189249)

Nuclear staining on paraffin-embedded sections of human thyroid carcinoma tissue, performed on a Leica Biosystems BOND® RX instrument. Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 2 (pH 9.0) for 20 minutes. Samples were incubated with primary antibody at a 1 : 10000 dilution (0.1 μg/ml). A Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Hematoxylin was used as the counterstain. A secondary antibody-only control was also performed.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [EPR13511] - C-terminal (AB189249)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [EPR13511] - C-terminal (AB189249)

Immunohistochemical analysis of formalin fixed paraffin embedded human thyroid carcinoma labeling PAX8 with ab189249 at a 1/500 dilution and HRP Polymer for Rabbit IgG. Counterstained with Hematoxylin.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-PAX8 antibody [EPR13511] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR13511

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

代替製品

Primary Antibodies

AB97477

Anti-PAX8 antibody

Immunocytochemistry/ Immunofluorescence - Anti-PAX8 antibody (AB97477)

  • 4
  • 2
Primary Antibodies

AB122944

Anti-PAX8 antibody [ZR-1]

  • 0
  • 0
Primary Antibodies

AB183573

Anti-PAX8 antibody [1F8-3A8]

Immunocytochemistry/ Immunofluorescence - Anti-PAX8 antibody [1F8-3A8] (AB183573)

  • 4
  • 1
Primary Antibodies

AB215953

Alexa Fluor® 647 Anti-PAX8 antibody [EPR18715]

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 647 Anti-PAX8 antibody [EPR18715] (AB215953)

  • 0
  • 0
Primary Antibodies

AB246332

Anti-PAX8 antibody [EPR18715] - BSA and Azide free

Recombinant|Advanced Validation|RabMAb

Immunocytochemistry/ Immunofluorescence - Anti-PAX8 antibody [EPR18715] - BSA and Azide free (AB246332)

  • 0
  • 0
Primary Antibodies

AB227707

Anti-PAX8 antibody [SP348] - N-terminal

BOND RX™ Validated|RabMAb|Advanced Validation|Recombinant|20ul selling size

Multiplex immunohistochemistry - Anti-PAX8 antibody [SP348] - N-terminal (AB227707)

  • 4
  • 1
Primary Antibodies

AB242429

Anti-PAX8 antibody [SP348] - BSA and Azide free

BOND RX™ Validated|RabMAb|Advanced Validation|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [SP348] - BSA and Azide free (AB242429)

  • 5
  • 1
Primary Antibodies

AB13611

Anti-PAX8 antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody (AB13611)

  • 4
  • 2
Primary Antibodies

AB53490

Anti-PAX8 antibody [PAX8R1]

Immunocytochemistry - Anti-PAX8 antibody [PAX8R1] (AB53490)

  • 3
  • 6
Primary Antibodies

AB214955

Alexa Fluor® 488 Anti-PAX8 antibody [EPR18715]

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 488 Anti-PAX8 antibody [EPR18715] (AB214955)

  • 0
  • 0
Primary Antibodies

AB181054

Anti-PAX8 antibody [EPR13510]

Recombinant|Advanced Validation|RabMAb

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PAX8 antibody [EPR13510] (AB181054)

  • 0
  • 0

組合せ製品

Primary Antibodies

AB89901

Anti-Wilms Tumor Protein antibody [CAN-R9(IHC)-56-2]

RabMAb|Recombinant|KO Validated|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Wilms Tumor Protein antibody [CAN-R9(IHC)-56-2] (AB89901)

  • 5
  • 43
Primary Antibodies

AB183734

Anti-GFP antibody [EPR14104]

RabMAb|Recombinant|Lab Essentials|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GFP antibody [EPR14104] (AB183734)

  • 5
  • 24
Primary Antibodies

AB16667

Anti-Ki67 antibody [SP6]

BOND RX™ Validated|KO Validated|RabMAb|Advanced Validation|Recombinant|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ki67 antibody [SP6] (AB16667)

  • 5
  • 133
Primary Antibodies

AB76013

Anti-TTF1/Nkx2-1 antibody [EP1584Y]

RabMAb|Recombinant|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TTF1/Nkx2-1 antibody [EP1584Y] (AB76013)

  • 5
  • 18
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200 - 1/10000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Dog": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Orangutan": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }
style
left-column

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Conditional Ambient
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

PAX8 also known as 3a8 is a transcription factor with a molecular mass of approximately 48 kDa. It belongs to the paired box (PAX) family of proteins which are characterized by a specific DNA-binding domain. PAX8 plays an important role in organ development and cellular differentiation. This protein is mainly expressed in the thyroid kidneys and Müllerian-derived tissues. Researchers often detect PAX8 using immunohistochemistry (PAX8 IHC) techniques due to its tissue-specific expression patterns.
Biological function summary

The PAX8 protein regulates the expression of genes related to organogenesis and cell fate determination. It forms part of transcriptional regulatory complexes partnering with other proteins to modulate gene activity. PAX8 supports embryonic development especially in the thyroid and urogenital tract. Its presence ensures the proper function and formation of these organs highlighting its significance in developmental biology.

Pathways

PAX8 interacts with several key biological processes. It notably participates in the thyroid hormone synthesis pathway where it regulates the expression of thyroglobulin and thyroperoxidase. PAX8 also affects the renal system through its interaction with WT1 a protein involved in kidney development. These pathways illustrate PAX8's role in maintaining endocrine and renal functions by influencing important protein interactions.

PAX8 mutations and dysregulation connect to conditions like congenital hypothyroidism and renal agenesis. In congenital hypothyroidism defects in PAX8 lead to impaired thyroid development affecting hormone production. Moreover its interaction with BCL2 an important apoptosis regulator relates to certain cancers such as ovarian carcinoma. The misregulation of PAX8 increases the risk and progression of these disorders by disrupting normal physiological processes.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

Transcription factor for the thyroid-specific expression of the genes exclusively expressed in the thyroid cell type, maintaining the functional differentiation of such cells.
See full target information PAX8
style
left-column

文献 (21)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:8136 PubMed40885711

2025

Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity.

Applications

Unspecified application

Species

Unspecified reactive species

Jack Schnell,Zhen Miao,MaryAnne Achieng,Connor C Fausto,Kari Koppitch,Lola Takhirov,Victoria Wang,Faith De Kuyper,Biao Huang,Megan Schreiber,Pedro Medina,Matthew E Thornton,Brendan Grubbs,Zhongwei Li,Junhyong Kim,Nils O Lindström

Nature communications 16:7912 PubMed40855070

2025

Axial nephron fate switching demonstrates a plastic system tunable on demand.

Applications

Unspecified application

Species

Unspecified reactive species

MaryAnne A Achieng,Jack Schnell,Connor C Fausto,Réka L Csipán,Kari Koppitch,Matthew E Thornton,Brendan H Grubbs,Nils O Lindström

Nature communications 16:4930 PubMed40436842

2025

An RNA transmethylation pathway governs kidney nephrogenic potential.

Applications

Unspecified application

Species

Unspecified reactive species

Harini Ramalingam,Jesus Alvarez,Andrea Flaten,Patricia Cobo-Stark,Nicholas Foster,Elyse Grilli,Ronak Lakhia,Karam Aboudehen,Thomas Carroll,Vishal Patel

Developmental cell 59:595-612.e8 PubMed38340720

2024

Identification of a core transcriptional program driving the human renal mesenchymal-to-epithelial transition.

Applications

Unspecified application

Species

Unspecified reactive species

John-Poul Ng-Blichfeldt,Benjamin J Stewart,Menna R Clatworthy,Julie M Williams,Katja Röper

Life medicine 2:lnad047 PubMed39872058

2023

Generation of renal tubular organoids from adult SOX9 kidney progenitor cells.

Applications

Unspecified application

Species

Unspecified reactive species

Dewei Zhou,Dandan Li,Hao Nie,Jun Duan,Sarah Liu,Yujia Wang,Wei Zuo

Cell reports. Medicine 4:101055 PubMed37220750

2023

Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Paula Cunnea,Edward W Curry,Elizabeth L Christie,Katherine Nixon,Chun Hei Kwok,Ahwan Pandey,Ratri Wulandari,Kerstin Thol,Jennifer Ploski,Cristina Morera-Albert,Stephen McQuaid,Jingky Lozano-Kuehne,James J Clark,Jonathan Krell,Euan A Stronach,Iain A McNeish,David D L Bowtell,Christina Fotopoulou

Cell stem cell 29:1083-1101.e7 PubMed35803227

2022

A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery.

Applications

Unspecified application

Species

Unspecified reactive species

Tracy Tran,Cheng Jack Song,Trang Nguyen,Shun-Yang Cheng,Jill A McMahon,Rui Yang,Qiuyu Guo,Balint Der,Nils O Lindström,Daniel C-H Lin,Andrew P McMahon

Cancers 13: PubMed34944908

2021

Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research.

Applications

Unspecified application

Species

Unspecified reactive species

Magdalena Cybula,Lin Wang,Luyao Wang,Ana Luiza Drumond-Bock,Katherine M Moxley,Doris M Benbrook,Camille Gunderson-Jackson,Maria J Ruiz-Echevarria,Resham Bhattacharya,Priyabrata Mukherjee,Magdalena Bieniasz

Developmental cell 56:2381-2398.e6 PubMed34428401

2021

Spatial transcriptional mapping of the human nephrogenic program.

Applications

Unspecified application

Species

Unspecified reactive species

Nils O Lindström,Rachel Sealfon,Xi Chen,Riana K Parvez,Andrew Ransick,Guilherme De Sena Brandine,Jinjin Guo,Bill Hill,Tracy Tran,Albert D Kim,Jian Zhou,Alicja Tadych,Aaron Watters,Aaron Wong,Elizabeth Lovero,Brendan H Grubbs,Matthew E Thornton,Jill A McMahon,Andrew D Smith,Seth W Ruffins,Chris Armit,Olga G Troyanskaya,Andrew P McMahon

STAR protocols 2:100314 PubMed33554147

2021

regeneration of neo-nephrons in rodents by renal progenitor cell transplantation.

Applications

Unspecified application

Species

Unspecified reactive species

Shuichiro Yamanaka,Kenji Matsui,Toshinari Fujimoto,Tsuyoshi Takamura,Yatsumu Saito,Naoto Matsumoto,Susumu Tajiri,Kei Matsumoto,Takashi Yokoo
View all publications
style
left-column
style
left-column
style
right-column

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com